Leucadia National Corporation »

United Therapeutics Corporation shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.8M 5.7k 318.55
2024-03-31 $4.6M 20k 229.72
2023-12-31 $2.3M 10k 219.89
2023-03-31 $323k 1.4k 223.96

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amgen (AMGN)
Nxp Semiconductors N V (NXPI)
Ishares Tr Russell 2000 Etf (IWM)
Shell Spon Ads (SHEL)
Argenx Se Sponsored Adr (ARGX)
Amazon (AMZN)
Wynn Resorts (WYNN)
Wal-Mart Stores (WMT)
Adapthealth Corp Common Stock (AHCO)
Abbvie (ABBV)

View all positions for Leucadia National Corporation

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation